相关实验视频
Updated: Sep 14, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.3K
异常的EZHIP表达驱动骨髓肉瘤中的瘤发生
Wajih Jawhar1,2,3, Geoffroy Danieau2,4, Alva Annett5,6
1Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Nature communications
|July 22, 2025
概括
EZHIP是一种模仿胆固醇蛋白的蛋白质,经常在骨髓瘤 (OS) 中发现. 它的表达预测治疗反应不佳,并通过改变表观遗传标记和阻碍细胞分化来驱动瘤的攻击性.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤 (OS) 是具有复杂遗传改变的侵袭性骨癌.
- 复发性瘤驱动突变在OS中很罕见,需要识别替代性致病机制.
研究的目的:
- 为了研究EZHIP (增强体质同类二相互作用蛋白) 在骨髓瘤病变发生过程中的作用.
- 为了确定EZHIP表达是否与患者的结果和对治疗的反应相关.
主要方法:
- 在两个独立的骨髓瘤患者队列中分析EZHIP表达.
- 功能增益和丧失实验以评估EZHIP在体外和体内的致癌活性.
- 评估H3K27me3沉积及其与治疗反应和患者预后的相关性.
主要成果:
- 在20%的骨髓肉瘤患者中发现了宫外EZHIP表达.
- 与EZHIP相关的降低的H3K27me3水平与新辅助疗法的组织学反应不佳和患者结果更差相关.
- EZHIP通过重新编程表观遗传标记,重新激活发育途径,并损害中原体对非平滑肌肉系的分化来促进OS的攻击性.
结论:
- EZHIP是骨髓瘤中普遍存在的驱动因素,有助于瘤的侵略性和不良预后.
- 由EZHIP介导的表观遗传变化阻碍了正常细胞分化,有利于更具侵略性的瘤表型.
- 在表达EZHIP的骨髓瘤中准EZH2可能是一个潜在的治疗策略.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

